Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies.
bacteria
cancer
colonization
immunotherapy
tumor model
vaccine
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2023
2023
Historique:
received:
09
01
2023
accepted:
30
03
2023
medline:
22
8
2023
pubmed:
21
8
2023
entrez:
21
8
2023
Statut:
epublish
Résumé
Immunotherapy has been emerging as a powerful strategy for cancer management. Recently, accumulating evidence has demonstrated that bacteria-based immunotherapy including naive bacteria, bacterial components, and bacterial derivatives, can modulate immune response
Identifiants
pubmed: 37600773
doi: 10.3389/fimmu.2023.1140463
pmc: PMC10436994
doi:
Substances chimiques
Antigens, Bacterial
0
Bacterial Vaccines
0
Types de publication
Systematic Review
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1140463Informations de copyright
Copyright © 2023 Zhou, Tang, Xu, Hao, Li, Huang, Xiang and Wu.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Biomed Mater Res A. 2014 Aug;102(8):2662-8
pubmed: 23982999
J Immunother Cancer. 2021 Jul;9(7):
pubmed: 34266884
Nanomaterials (Basel). 2021 Nov 10;11(11):
pubmed: 34835785
Biomaterials. 2022 Feb;281:121332
pubmed: 35066286
Cancers (Basel). 2016 Jun 28;8(7):
pubmed: 27367731
Cancer Biol Ther. 2019;20(6):866-876
pubmed: 30786815
J Immunother. 2014 Jun;37(5):257-66
pubmed: 24810637
Vet Res. 2018 Apr 24;49(1):38
pubmed: 29690928
Angew Chem Int Ed Engl. 2022 Jul 4;61(27):e202202409
pubmed: 35403784
Cancer Lett. 2020 Mar 1;472:19-28
pubmed: 31857157
Adv Sci (Weinh). 2021 Feb 10;8(7):2003572
pubmed: 33854892
Cell Microbiol. 2020 Apr;22(4):e13175
pubmed: 32185899
Front Immunol. 2019 Jan 31;9:3154
pubmed: 30766539
Pathol Oncol Res. 2022 Aug 30;28:1610555
pubmed: 36110249
Adv Sci (Weinh). 2019 Jul 15;6(16):1900288
pubmed: 31453059
Cancer Discov. 2021 Jul;11(7):1792-1807
pubmed: 33632774
Hum Vaccin Immunother. 2018 Jan 2;14(1):159-162
pubmed: 29048978
ESMO Open. 2017 Aug 22;2(3):e000218
pubmed: 29209524
Biomed Pharmacother. 2022 Jan;145:112443
pubmed: 34847476
Cancer Immunol Immunother. 2017 Feb;66(2):149-159
pubmed: 27864613
Drugs. 2014 Jan;74(1):15-30
pubmed: 24338083
Toxins (Basel). 2018 Jul 20;10(7):
pubmed: 30037010
Biomaterials. 2022 Jul;286:121582
pubmed: 35609407
JCI Insight. 2020 Apr 23;5(8):
pubmed: 32324171
Nano Lett. 2021 May 26;21(10):4231-4240
pubmed: 33998789
J Immunother. 2015 Sep;38(7):276-84
pubmed: 26261891
Adv Mater. 2022 Feb;34(7):e2106307
pubmed: 34859919
Microb Pathog. 2019 Jan;126:149-156
pubmed: 30391536
Int J Pharm. 2021 Aug 10;605:120817
pubmed: 34166726
ACS Nano. 2020 Dec 22;14(12):16698-16711
pubmed: 33232124
Nano Lett. 2022 Jun 22;22(12):5055-5064
pubmed: 35583490
Adv Drug Deliv Rev. 2022 Jul;186:114340
pubmed: 35569561
Front Immunol. 2022 Dec 20;13:1017780
pubmed: 36605208
Am J Pathol. 2018 Aug;188(8):1736-1743
pubmed: 29870741
Appl Microbiol Biotechnol. 2021 Aug;105(16-17):6183-6197
pubmed: 34402938
PLoS One. 2022 Oct 7;17(10):e0275776
pubmed: 36206297
Proteomics. 2019 Jan;19(1-2):e1800209
pubmed: 30488570
ACS Nano. 2022 Mar 22;16(3):4102-4115
pubmed: 35262333
Int J Biol Macromol. 2018 Jan;106:730-738
pubmed: 28823704
Mol Pharm. 2018 Dec 3;15(12):5762-5771
pubmed: 30380885
Cancer Immunol Immunother. 2017 Jun;66(6):787-798
pubmed: 28299466
Nano Lett. 2022 Jun 8;22(11):4491-4500
pubmed: 35605283
Expert Rev Vaccines. 2014 Oct;13(10):1215-27
pubmed: 25090574
Nat Commun. 2021 Nov 15;12(1):6584
pubmed: 34782610
Adv Healthc Mater. 2021 Nov;10(21):e2100950
pubmed: 34541825
Mol Ther. 2022 Jul 6;30(7):2522-2536
pubmed: 35440418
Br J Cancer. 2014 Nov 11;111(10):1945-54
pubmed: 25314062
Front Immunol. 2018 Feb 26;9:341
pubmed: 29535722
Microb Cell Fact. 2018 Oct 3;17(1):157
pubmed: 30285743
Oncoimmunology. 2022 Jan 20;11(1):2023340
pubmed: 35083095
Nat Commun. 2020 Jun 1;11(1):2739
pubmed: 32483165
Nano Lett. 2020 Jan 8;20(1):11-21
pubmed: 31858807
Front Immunol. 2018 Jan 23;9:7
pubmed: 29410666
Front Immunol. 2021 Feb 23;12:622995
pubmed: 33708215
Front Immunol. 2021 Aug 19;12:712936
pubmed: 34489962
J Immunother Cancer. 2017 Aug 15;5(1):64
pubmed: 28807056
mBio. 2016 Sep 06;7(5):
pubmed: 27601574
Cancer Lett. 2020 Jan 28;469:102-110
pubmed: 31666180
Nat Protoc. 2022 Oct;17(10):2240-2274
pubmed: 35879454
Transl Cancer Res. 2022 Jun;11(6):1595-1602
pubmed: 35836530
Food Funct. 2022 Oct 3;13(19):10023-10033
pubmed: 36069328
Exp Mol Med. 2017 Sep 1;49(9):e373
pubmed: 28860663
Nat Commun. 2018 Apr 23;9(1):1591
pubmed: 29686284
Int J Nanomedicine. 2022 May 02;17:1971-1985
pubmed: 35530972
J Extracell Vesicles. 2021 Jul;10(9):e12120
pubmed: 34262675
Oncoimmunology. 2018 Feb 16;7(5):e1424676
pubmed: 29721389
Vaccines (Basel). 2014 Jun 13;2(2):422-62
pubmed: 26344626
Adv Drug Deliv Rev. 2022 Jul;186:114321
pubmed: 35533789
Front Immunol. 2020 Nov 06;11:583382
pubmed: 33240271
ACS Nano. 2021 Dec 28;15(12):19321-19333
pubmed: 34851608
Nat Med. 2022 Mar;28(3):545-556
pubmed: 35228752
Adv Mater. 2018 Dec;30(52):e1805007
pubmed: 30387230
Pediatr Res. 2017 Jan;81(1-2):170-176
pubmed: 27701380
Pharmaceutics. 2022 Apr 03;14(4):
pubmed: 35456618
Biomaterials. 2018 Dec;187:28-38
pubmed: 30292939
Sci Rep. 2013;3:2203
pubmed: 23857555
Clin Cancer Res. 2021 Jan 1;27(1):96-106
pubmed: 33046513
Front Immunol. 2022 Nov 11;13:1038807
pubmed: 36439126
Expert Rev Vaccines. 2021 Aug;20(8):1001-1011
pubmed: 34224293
Cell Microbiol. 2020 Apr;22(4):e13187
pubmed: 32185897
mBio. 2017 May 9;8(3):
pubmed: 28487429
Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1175-1178
pubmed: 29722659
Nat Commun. 2022 Dec 3;13(1):7466
pubmed: 36463242
Immunology. 2021 Nov;164(3):476-493
pubmed: 34322877
Cell Host Microbe. 2021 Oct 13;29(10):1573-1588.e7
pubmed: 34453895
Biochem Biophys Res Commun. 2018 Mar 18;497(4):1055-1061
pubmed: 29481803
J Control Release. 2020 Jul 10;323:253-268
pubmed: 32333919
Biomaterials. 2021 Jan;268:120550
pubmed: 33278684
Oncoimmunology. 2017 Jan 19;6(3):e1282589
pubmed: 28405506
Nat Commun. 2017 Sep 20;8(1):626
pubmed: 28931823
Front Bioeng Biotechnol. 2022 Sep 29;10:996055
pubmed: 36246355
Oncol Rep. 2015 Jun;33(6):2837-44
pubmed: 25872647
Oncotarget. 2017 May 16;8(20):33601-33613
pubmed: 28431394
Science. 2021 Mar 26;371(6536):
pubmed: 33766858
J Appl Microbiol. 2021 Jun;130(6):2063-2074
pubmed: 33128836
Nat Commun. 2021 May 5;12(1):2537
pubmed: 33953170
Cancers (Basel). 2020 Jul 05;12(7):
pubmed: 32635668
Mol Ther. 2014 Jun;22(6):1188-1197
pubmed: 24569832
Int J Nanomedicine. 2021 Apr 20;16:2949-2963
pubmed: 33907401
ACS Appl Mater Interfaces. 2021 Feb 3;13(4):4844-4852
pubmed: 33486952
Cancer Immunol Immunother. 2021 Sep;70(9):2529-2543
pubmed: 33570675
J Drug Target. 2021 Apr;29(4):430-438
pubmed: 33183080
Proc Natl Acad Sci U S A. 2018 Aug 7;115(32):8179-8184
pubmed: 30038013
PLoS One. 2013 Jul 15;8(7):e68864
pubmed: 23874793
ACS Nano. 2022 Jul 26;16(7):11325-11337
pubmed: 35819107
Cell. 2018 Oct 4;175(2):313-326
pubmed: 30290139
Front Oncol. 2021 Mar 02;11:624759
pubmed: 33738260
Nanoscale Adv. 2022 Feb 7;4(6):1577-1586
pubmed: 36134371
J Immunother. 2018 Apr;41(3):125-129
pubmed: 29293165
Adv Sci (Weinh). 2017 Jun 15;4(10):1700083
pubmed: 29051851
Front Immunol. 2019 Aug 02;10:1839
pubmed: 31428106
Exp Mol Med. 2019 Dec 11;51(12):1-15
pubmed: 31827064
Immunity. 2021 Dec 14;54(12):2690-2692
pubmed: 34910936
Int J Cancer. 2015 Oct 15;137(8):2019-28
pubmed: 25868911
Cancers (Basel). 2019 Dec 24;12(1):
pubmed: 31878272
Nat Biomed Eng. 2022 Jan;6(1):44-53
pubmed: 35058589
ACS Nano. 2021 Mar 23;15(3):4845-4860
pubmed: 33625212
Mol Cancer Ther. 2019 May;18(5):980-990
pubmed: 30824610
Small. 2022 Feb;18(8):e2105716
pubmed: 34889048
Biochim Biophys Acta Rev Cancer. 2020 Aug;1874(1):188388
pubmed: 32589907
Sci Rep. 2018 Aug 30;8(1):13062
pubmed: 30166607
Nat Rev Drug Discov. 2017 Mar 30;16(4):240
pubmed: 28356590
Nat Commun. 2022 Sep 1;13(1):5127
pubmed: 36050316
Nano Lett. 2015 Apr 8;15(4):2732-9
pubmed: 25806599
Adv Mater. 2022 Jan;34(1):e2106669
pubmed: 34687102
Adv Mater. 2020 Nov;32(47):e2002085
pubmed: 33015871
Acta Pharm Sin B. 2020 Aug;10(8):1534-1548
pubmed: 32963948
J Immunol. 2020 Feb 15;204(4):990-1000
pubmed: 31900334
Front Immunol. 2021 Apr 20;12:607178
pubmed: 33959120
Front Cell Infect Microbiol. 2014 May 12;4:51
pubmed: 24860789
Front Immunol. 2016 Mar 01;7:72
pubmed: 26973649
Curr Opin Immunol. 2022 Apr;75:102171
pubmed: 35219942
Front Microbiol. 2021 Jun 08;12:669488
pubmed: 34168629
ACS Nano. 2021 Jan 26;15(1):1100-1110
pubmed: 33236885
Expert Opin Drug Discov. 2014 Jul;9(7):741-50
pubmed: 24949888
Cancer Cell. 2021 Dec 13;39(12):1576-1577
pubmed: 34906317
Nat Commun. 2022 Mar 24;13(1):1585
pubmed: 35332124
Nat Med. 2019 Jul;25(7):1057-1063
pubmed: 31270504
J Exp Med. 2020 May 4;217(5):
pubmed: 32142585
Gastroenterology. 2016 Jul;151(1):206-7
pubmed: 27238844
J Drug Target. 2021 Mar;29(3):294-299
pubmed: 32886538
Biochem Biophys Res Commun. 2018 Feb 5;496(2):778-783
pubmed: 29217193
Eur J Pharm Biopharm. 2020 Oct;155:69-76
pubmed: 32798667
J Control Release. 2020 Oct 10;326:396-407
pubmed: 32681947
J Extracell Vesicles. 2022 Dec;11(12):e12289
pubmed: 36468941
Biomaterials. 2022 Jun 5;287:121619
pubmed: 35700622
Nat Biotechnol. 2022 Aug;40(8):1259-1269
pubmed: 35301496
Cancer Res. 2016 Nov 1;76(21):6146-6152
pubmed: 27729325
Front Immunol. 2018 Apr 23;9:822
pubmed: 29755461
Adv Mater. 2022 May;34(20):e2109984
pubmed: 35315546
Int J Cancer. 2013 Feb 1;132(3):717-25
pubmed: 22736433
Expert Rev Vaccines. 2013 Oct;12(10):1139-54
pubmed: 24124876
Front Immunol. 2021 Feb 25;12:615930
pubmed: 33717106
Cancer Res. 2016 Aug 15;76(16):4602-7
pubmed: 27474734
J Nanobiotechnology. 2021 Dec 20;19(1):434
pubmed: 34930285
J Control Release. 2022 Nov;351:860-871
pubmed: 36181917
ACS Appl Mater Interfaces. 2022 Aug 17;14(32):36411-36424
pubmed: 35917371
ACS Appl Mater Interfaces. 2022 Mar 23;14(11):13094-13106
pubmed: 35262323
J Control Release. 2014 Dec 28;196:384-93
pubmed: 25466954
Science. 2015 Nov 27;350(6264):1084-9
pubmed: 26541606
Trends Mol Med. 2017 Jul;23(7):580-582
pubmed: 28583420
J Immunol. 2016 May 15;196(10):4014-29
pubmed: 27084100
Science. 2020 Sep 18;369(6510):1481-1489
pubmed: 32792462
Proc Natl Acad Sci U S A. 2022 Jun 14;119(24):e2202719119
pubmed: 35675425
Science. 2019 Jun 21;364(6446):1179-1184
pubmed: 31221858
Trends Cancer. 2021 Jul;7(7):647-660
pubmed: 33674230
Eur J Immunol. 2021 Dec;51(12):3228-3238
pubmed: 34633664
Biotechnol Adv. 2022 Jan-Feb;54:107869
pubmed: 34793882
Sci Transl Med. 2017 Feb 8;9(376):
pubmed: 28179508
Theranostics. 2019 May 31;9(14):4115-4129
pubmed: 31281535
Adv Sci (Weinh). 2022 May;9(14):e2105807
pubmed: 35277932
Radiat Oncol. 2013 Oct 16;8:239
pubmed: 24131485
Eur J Cancer. 2017 Jan;70:48-61
pubmed: 27883926
Nature. 2019 Sep;573(7774):434-438
pubmed: 31511694
Gut Microbes. 2016;7(2):171-7
pubmed: 26939530
Theranostics. 2021 Jan 15;11(7):3301-3316
pubmed: 33537088
Front Immunol. 2022 Jul 15;13:935846
pubmed: 35911695
Immune Netw. 2022 Feb 14;22(1):e3
pubmed: 35291651
Cancers (Basel). 2021 Jun 28;13(13):
pubmed: 34203478
J Drug Target. 2015 Jun;23(5):462-8
pubmed: 25673265
Small. 2022 Apr;18(14):e2107461
pubmed: 35152555
J Immunother Cancer. 2019 Apr 17;7(1):108
pubmed: 30995949
Toxins (Basel). 2020 Apr 09;12(4):
pubmed: 32283684
Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188494
pubmed: 33346129
Nat Commun. 2022 Aug 2;13(1):4468
pubmed: 35918309
Adv Healthc Mater. 2022 Jan;11(2):e2101487
pubmed: 34738725
Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18627-18637
pubmed: 32680964
Appl Microbiol Biotechnol. 2021 Feb;105(4):1395-1405
pubmed: 33492450
Mol Ther. 2013 May;21(5):1076-86
pubmed: 23531551
J Cell Biochem. 2018 Jan;119(1):634-639
pubmed: 28628234
Sci Transl Med. 2021 May 19;13(594):
pubmed: 34011627
Cancers (Basel). 2020 Oct 28;12(11):
pubmed: 33126513
Nat Biotechnol. 2018 Feb 6;36(2):121-123
pubmed: 29406499
Oncoimmunology. 2015 Mar 16;4(4):e1001217
pubmed: 26137397
Science. 2015 Nov 27;350(6264):1079-84
pubmed: 26541610
J Extracell Vesicles. 2019 Jun 24;8(1):1632099
pubmed: 31275533
Curr Opin Genet Dev. 2014 Feb;24:46-51
pubmed: 24657536
Biomaterials. 2017 Jan;113:68-79
pubmed: 27810643
Int Immunopharmacol. 2017 Oct;51:57-65
pubmed: 28802902
Nat Commun. 2021 Apr 6;12(1):2041
pubmed: 33824314
Microb Biotechnol. 2019 Sep;12(5):828-844
pubmed: 30834674
Cancer Immunol Res. 2014 Sep;2(9):911-22
pubmed: 24872025
Genes Dis. 2016 Feb 06;3(2):144-152
pubmed: 30258882
Cancer Med. 2022 Dec;11(23):4457-4468
pubmed: 35522104
Pharmacol Res. 2022 Aug;182:106282
pubmed: 35662630
Front Immunol. 2021 Dec 14;12:772532
pubmed: 34970262
J Immunother Cancer. 2022 Jan;10(1):
pubmed: 34987022
Appl Microbiol Biotechnol. 2019 Dec;103(23-24):9401-9410
pubmed: 31676919
Blood. 2013 Aug 1;122(5):705-14
pubmed: 23736700
Vaccine. 2010 Jul 5;28(30):4810-6
pubmed: 20483197
J Immunother Cancer. 2022 Jul;10(7):
pubmed: 35781395
Cancer Discov. 2021 Dec 1;11(12):2956
pubmed: 34654704
Mol Med Rep. 2020 Jul;22(1):362-370
pubmed: 32319653
Adv Mater. 2020 Apr;32(16):e1908185
pubmed: 32108390
Cancer Lett. 2013 May 1;331(2):167-73
pubmed: 23337288
Mater Horiz. 2021 May 1;8(5):1454-1460
pubmed: 34846453
Front Immunol. 2021 Apr 14;12:642316
pubmed: 33936058
Eur J Cancer. 2021 Jul;151:25-34
pubmed: 33962358
Front Immunol. 2022 Jun 10;13:911783
pubmed: 35757741
Oncoimmunology. 2017 Oct 16;7(2):e1382791
pubmed: 29308303
Nutrients. 2021 Jul 31;13(8):
pubmed: 34444834
PLoS One. 2013 May 31;8(5):e65157
pubmed: 23741478
Front Immunol. 2019 Nov 22;10:2737
pubmed: 31824511
Small. 2022 Apr;18(13):e2104763
pubmed: 35076148
Nat Rev Cancer. 2018 Dec;18(12):727-743
pubmed: 30405213
Int J Mol Sci. 2020 Sep 09;21(18):
pubmed: 32916853
Nature. 2021 Oct;598(7882):662-666
pubmed: 34616044
Sci Rep. 2017 Mar 16;7:44776
pubmed: 28300196
Cancer Res. 2014 Aug 15;74(16):4217-21
pubmed: 25074615
Sci Adv. 2020 Aug 14;6(33):eaba3546
pubmed: 32851163
Oncoimmunology. 2022 May 27;11(1):2081010
pubmed: 35655708
Pharmaceutics. 2021 Sep 09;13(9):
pubmed: 34575506
Prostate Cancer Prostatic Dis. 2022 Feb;25(2):219-228
pubmed: 34257408
J Immunol. 2013 Aug 15;191(4):1984-92
pubmed: 23858033
Cancer Biol Med. 2022 Sep 23;19(9):
pubmed: 36172794
Cancer Immunol Immunother. 2015 Oct;64(10):1215-27
pubmed: 26076666
Pharmacol Ther. 2022 Jul;235:108158
pubmed: 35183590
Commun Biol. 2020 Oct 9;3(1):561
pubmed: 33037315